Anti-KIR2DL5 mAb F8B30, which was able to effectively block KIR2DL5-PVR interaction, significantly enhanced the tumor lysis by KIR2DL5+ primary NK cells (Figure 4F, scrambled control). The gene discussed is PVR; the disease is neoplasm.